A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea
暂无分享，去创建一个
D. Gill | W. Colledge | C. Goddard | R. Ratcliff | S. Hyde | Mj Evans | A. Cuthbert | C. Higgins | S. Brown | L. Huang | L. MacVinish | J. Anderson | E. Glenn
[1] D. Porteous,et al. Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. , 1996, Gene therapy.
[2] R. Crystal,et al. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. , 1995, Human gene therapy.
[3] B. Abella,et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model , 1995, Nature Genetics.
[4] R. Boucher,et al. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice. , 1994, The American journal of physiology.
[5] G. Nabel,et al. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. , 1993, Human gene therapy.
[6] M. Evans,et al. Production of a severe cystic fibrosis mutation in mice by gene targeting , 1993, Nature Genetics.
[7] E. Nabel,et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. , 1992, Human gene therapy.
[8] M. Tsan,et al. HUMORAL AND CELLULAR IMMUNE RESPONSES TO PRP , 1977, Pediatric Research.